BioMarin Pharmaceutical Inc.
BMRN
$52.88
$0.300.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 74.67% | 37.17% | 58.83% | 16.97% | 21.57% |
| Total Receivables | 22.29% | 37.50% | 1.64% | 23.82% | 16.01% |
| Inventory | -0.13% | 5.37% | 17.20% | 13.23% | 12.03% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 13.20% | -7.81% | 20.68% | 10.45% | 11.18% |
| Total Current Assets | 32.79% | 22.31% | 26.11% | 16.74% | 16.18% |
|
|
|||||
| Total Current Assets | 32.79% | 22.31% | 26.11% | 16.74% | 16.18% |
| Net Property, Plant & Equipment | -7.22% | -7.89% | -0.69% | -2.14% | -2.62% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -17.26% | -3.16% | -10.66% | -9.76% | -11.55% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 54.87% | 0.50% | 3.28% | -3.06% | -1.36% |
| Total Assets | 20.20% | 8.66% | 11.15% | 5.51% | 3.99% |
|
|
|||||
| Total Accounts Payable | 34.63% | 32.86% | 24.77% | 20.74% | 0.52% |
| Total Accrued Expenses | 25.20% | 19.03% | -7.08% | 8.09% | 6.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 47.71% | 14.67% | -5.98% | -98.48% | -98.75% |
| Total Finance Division Other Current Liabilities | -18.45% | 32.14% | 66.97% | 111.33% | 58.57% |
| Total Other Current Liabilities | -18.45% | 32.14% | 66.97% | 111.33% | 58.57% |
| Total Current Liabilities | 26.26% | 25.05% | 11.57% | -35.89% | -42.25% |
|
|
|||||
| Total Current Liabilities | 26.26% | 25.05% | 11.57% | -35.89% | -42.25% |
| Long-Term Debt | 140.12% | 0.34% | 0.34% | 0.34% | 0.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 18.41% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.89% | 16.64% | 27.87% | 24.67% | 10.51% |
| Total Liabilities | 75.75% | 13.23% | 8.37% | -19.74% | -24.76% |
|
|
|||||
| Common Stock & APIC | 2.98% | 2.66% | 2.81% | 2.72% | 3.11% |
| Retained Earnings | 2,983.04% | 179.20% | 162.81% | 154.38% | 98.31% |
| Treasury Stock & Other | -284.19% | -147.56% | -539.99% | -471.80% | 162.56% |
| Total Common Equity | 7.23% | 7.58% | 11.88% | 14.01% | 14.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.23% | 7.58% | 11.88% | 14.01% | 14.18% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.23% | 7.58% | 11.88% | 14.01% | 14.18% |
|
|
|||||